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Abstract: 39 
Early acclimatization to high-altitude is characterized by various respiratory, hematological, and 40 
cardiovascular adaptations that serve to restore oxygen delivery to tissue. However, less is 41 
understood about renal function and the role of renal oxygen delivery (RDO2) during high-42 
altitude acclimatization. We hypothesized that: 1) RDO2 would be reduced after 12-hours of 43 
high-altitude exposure (high-altitude day1) but restored to sea-level values after one-week (high-44 
altitude day7); and 2) RDO2 would be associated with renal reactivity (RR), an index of acid-45 
base compensation at high-altitude. Twenty-four healthy lowlander participants were tested at 46 
sea-level (344m; Kelowna, Canada), on day1 and day7 at high-altitude (4330m; Cerro de Pasco, 47 
Peru). Cardiac output, renal blood flow, arterial and venous blood sampling for renin-48 
angiotensin-aldosterone-system hormones and NT pro-B type natriuretic peptides were collected 49 
at each time point. RR was calculated as: (Δ arterial bicarbonate)/(Δ partial pressure of arterial 50 
carbon dioxide) between sea-level and high-altitude day1, and sea-level and high-altitude day7. 51 
The main findings were: 1) RDO2 was initially decreased at high-altitude compared to sea-level 52 
(ΔRDO2: -22±17%, P<0.001), but was restored to sea-level values on high-altitude day7 53 
(ΔRDO2: -6±14%, P=0.36). The observed improvements in RDO2 resulted from both changes in 54 
renal blood flow (Δ from high-altitude day1: +12±11%; P=0.008), and arterial oxygen content (Δ 55 
from high-altitude day1 +44.8±17.7%; P=0.006); and 2) RR was positively correlated with 56 
RDO2 on high-altitude day7 (r=0.70; P<0.001), but not high-altitude day1 (r=0.26; P=0.29). 57 
These findings characterize the temporal responses of renal function during early high-altitude 58 
acclimatization, and the influence of RDO2 in the regulation of acid-base.   59 
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Introduction:  60 
High-altitude acclimatization is characterized by varying elevations in ventilation, 61 
hemoglobin concentration, heart rate, and redistribution of blood flow, which serves to restore 62 
arterial oxygen content (CaO2) and preserve oxygen delivery to vital organs (10, 13, 44, 53, 56). 63 
Alterations in renal function are also critical during high-altitude acclimatization; however, there 64 
are few studies exploring renal acclimatization in comparison to ventilatory and hematological 65 
factors (4, 10, 22, 43). This is noteworthy since there are unique characteristics of renal 66 
oxygenation that renders the kidney susceptible to hypoxia. For example, the partial pressure of 67 
oxygen (PO2) in renal tissue is typically tightly controlled through a coupling between renal 68 
blood flow (i.e. oxygen delivery) and sodium reabsorption load (i.e. oxygen utilization) (31). 69 
Hence, unlike other tissues, greater renal blood flow does not necessarily influence renal 70 
oxygenation since renal oxygen consumption (i.e. metabolic rate) can rapidly adapt to maintain 71 
constant oxygen delivery (31). Furthermore, portions of the medulla have a tissue PO2 of ~10-15 72 
mmHg, which is near the “critical PO2”, which the enzyme mitochondrial cytochrome oxidase 73 
becomes reduced, in turn limiting adenosine triphosphate production (25, 30). This, coupled with 74 
the fact that 95-99% of renal energy is via oxidative phosphorylation (30), highlights the 75 
importance of controlled renal oxygen delivery (RDO2) for normal kidney function (7). Despite 76 
the kidney’s precise maintenance of RDO2 in normoxia, RDO2 has not been quantified during 77 
early acclimatization to severe hypoxia (e.g. >4000 m).  78 
While data sets are limited, renal blood flow (as indexed via the effective renal plasma 79 
flow) appears to decrease following acute (48-hours) exposure to 4350 m (37) and following a 80 
60 day stay at 3500 m (43). Only two studies to our knowledge (37, 38) have investigated the 81 
mechanism(s) regulating renal blood flow at high-altitude. Olsen and colleagues (37) reported a 82 
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reduction in effective renal blood flow indicating a pre-existing increase in renal vascular tone. 83 
The authors from this study speculated that elevated catecholamines (e.g. noradrenaline), were 84 
responsible for the observed renal vasoconstriction and consequential reduction in renal blood 85 
flow. However, systemic hypoxia stimulates numerous factors that independently influence renal 86 
blood flow control such as natriuretic peptides (5) and RAAS hormones (6, 13). Specifically, the 87 
influence of renin during hypoxia has been unclear: some studies have reported that renin is 88 
elevated (12, 35, 40) while others have documented no change (3, 45) and others still have 89 
reported a decrease (6, 37). To our knowledge, no study has investigated the integrative 90 
mechanisms controlling renal blood flow at high-altitude following 12-hours and a week of 91 
acclimatization.  92 
Under normal oxygen conditions (e.g. sea-level), arterial oxygen content (CaO2) is 93 
relatively stable and RDO2 is directly related to renal blood flow (31). However, since early 94 
exposure to high-altitude decreases both renal blood flow (37), and CaO2 (43), this may hence 95 
effectively decrease RDO2. Yet, RDO2 may return to sea-level values as CaO2 becomes restored 96 
with acclimatization (19, 43), which may offset the high-altitude related reductions in renal 97 
blood flow, and mediates the reduction in RDO2 as demonstrated in animal studies (48). To our 98 
knowledge no study has characterized RDO2 during acclimatization to high-altitude in humans.  99 
The contributions of renal blood flow and CaO2 on RDO2 has yet to be characterized at high-100 
altitude, and may have functional consequences on acid-base acclimatization (18, 49). 101 
The tight regulation of blood pH is critical for homeostasis and regular cellular function. 102 
High-altitude driven hyperventilation decreases the partial pressure of arterial carbon dioxide 103 
(PaCO2), resulting in respiratory alkalosis (10, 47). Renal acid (H
+) retention and bicarbonate 104 
(HCO3)
- excretion aims to normalize arterial pH towards standard sea-level values (pH ~ 7.4) (9, 105 
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13, 28, 43, 45). A recent study by Zouboules and colleagues (58) proposed a novel renal 106 
reactivity index (Δ[HCO3
−]/Δ [PaCO2]), to quantify the relationship between HCO3
- and PaCO2 107 
at high-altitude (58). While bicarbonate excretion occurs to normalize pH as a function of 108 
PaCO2, this response might be linked to RDO2, since bicarbonate reabsorption is dependent on 109 
renal cortex tissue PO2 in hypoxic animals (49).  110 
The purpose of the current investigation was to assess the mechanism(s) that govern renal 111 
oxygen delivery during early high-altitude acclimatization. We hypothesized the following: 1) 112 
after rapid ascent from sea-level to high-altitude (4330 m), RDO2 would decrease 12-hours after 113 
arrival, but thereafter following a week of acclimatization, RDO2 would increase through an 114 
increase in arterial oxygen delivery rather than renal blood flow; and 2) an association between 115 
RDO2 and renal reactivity would be present after 12-hours and one week of high-altitude 116 
acclimatization.   117 
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Methods: 118 
Ethical Approval 119 
This a priori study was conducted as part of the Global Research Expedition on Altitude-120 
Related Chronic Health (REACH) expedition to Instituto de Investigacions de Altura at Cerro de 121 
Pasco, Peru (4330 m). Participants were researchers involved in the expedition and as such were 122 
in numerous studies; however, care was taken to ensure adequate washout between studies to 123 
avoid cross-over or contamination between investigations. An overview of our research team’s 124 
expedition has been previously published (50).  125 
This study abided by the Canadian Government Tri-council Policy on Research Ethics 126 
Policy Statement (TCPS2) and the Declaration of Helsinki, apart from registration in a publicly 127 
accessible database. Ethical approval was obtained in advanced through the Clinical Research 128 
Ethics Board of the University of British Columbia (H17-02687 and H18-01404), the University 129 
of Alberta Biomedical Ethics 100 Board (Pro00077330) and the Universidad Peruana Cayetano 130 
Heredia Comité de Ética (no. 101686). Participants were given in-depth study information and 131 
provided written consent.  132 
 133 
Participants  134 
Participants (20 males, 4 females) were recruited from the research expedition team and 135 
had no history of pre-existing neurological, cardiovascular or renal dysfunction prior to testing. 136 
Participants were born and lived at or near sea-level and had not traveled to high-altitude within 137 
6 months prior to experimentation (50). 138 
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 139 
Experimental overview 140 
  Sea-level testing occurred at the University of British Columbia – Okanagan Campus, BC 141 
(altitude = ~344 m) ~three months prior to departure to high-altitude. The research team travelled 142 
to Lima, Peru (altitude = ~150m) in June 2018, spent three days in Lima before the expedition 143 
preparing to depart and then traveled via automobile directly to Cerro de Pasco, Peru (4330 m) 144 
over 6-8 hours. Participants were tested the morning immediately following ascent having spent 145 
~12-hours at high-altitude (high-altitude day1), and again following seven days of 146 
acclimatization (high-altitude day7).  147 
At both sea-level and high-altitude participants arrived at the laboratory between 0600 148 
and 1030 following a 12-hour fast and having avoided caffeine, alcohol and exercise. 149 
Throughout the week of acclimatization, participants were asked to avoid exercise to not 150 
contaminate results.  Participants were asked to complete a nine-hour urinary collection from the 151 
previous night, which was used to calculate glomerular filtration rate. Participants were asked to 152 
complete an acute mountain sickness questionnaire at high-altitude prior to testing on both high-153 
altitude day1 and high-altitude day7 (i.e. Lake Louise Questionnaire) (41). Experimentation 154 
commenced with participants laying supine and resting quietly for ~ten-minutes prior to 155 
collecting measurements of renal blood flow via duplex ultrasound, venous blood samples, 156 
echocardiography, and radial artery blood samples were taken. These methodologies are 157 
discussed in further detail below.  158 
 159 
Lake Louise acute mountain sickness scores 160 
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Acute mountain sickness was identified using the standard 2018 Lake Louis acute mountain 161 
sickness scoring system. As per the recommendations, the scoring system was not used until at 162 
least six hours prior of ascent. Acute mountain sickness is identified via four categories: 163 
headache, gastrointestinal symptoms, fatigue and/or weakness and dizziness/light-headedness 164 
with each category with a score between 0-3. Acute mountain sickness is diagnosed as a score of 165 
three with an associated headache. As per the guidelines, participants with mild symptoms of 166 
acute mountain sickness had scores between 3-5; moderate between 6-9 and severe 10-12 points 167 
[refer to (41) for more details]. 168 
 169 
Heart rate and blood pressure  170 
Continuous heart rate (electrocardiogram Lead II) was recorded and integrated with a 171 
data acquisition system (Powerlab 16/30; ADInstruments, Australia) and stored for subsequent 172 
analysis using associated software (Labchart 8.0 Pro; ADInstruments, Australia). Systolic and 173 
diastolic blood pressures were measured using an automated cuff (Omron M2 Classic; Japan). 174 
Mean arterial pressure was subsequently calculated as: (1/3 x systolic blood pressure) + (2/3 x 175 
diastolic blood pressure). Arterial oxygen saturation was estimated by pulse oximetry (N‐595; 176 
Nellcor Oximax, Boulder, USA) using an index finger sensor.  177 
 178 
Blood measures 179 
Venous blood samples were taken from the antecubital vein immediately centrifuged, 180 
aliquoted and frozen until analysis in Edmonton, Alberta, Canada. Frozen samples were 181 
transported by a commercial company (Marken, New York, USA). Plasma aldosterone 182 
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concentration (LDN REF: MS E-5200) and active renin (LDN REF: MS E-5300) were measured 183 
using a solid phase enzyme-linked immunosorbent assay (ELISA), based on the principle of 184 
competitive binding. N-terminal pro-B-type natriuretic peptide (NT pro-BNP) (R&D systems 185 
REF: DY3604-05) was quantified using a sandwich solid phase ELISA.  186 
Radial artery blood samples were collected using a lithium heparin-coated auto fill 187 
syringe and analyzed using point-of-care device i-STAT (Abbott Laboratories, Chicago, USA) 188 
for blood gases using the CG4+ (lactate, pH, PaCO2, arterial partial pressure of oxygen (PaO2), 189 
HCO3
-and oxygen saturation (SaO2)), and CHEM8+ (glucose, urea nitrogen, creatinine, sodium, 190 
potassium, chloride, ionized calcium, TCO2, anion gap, hematocrit and hemoglobin) test 191 
cartridges. The point of care device, i-STAT, has been validated on altitude up to 5043 meters 192 
(32). 193 
CaO2 was calculated with measures of oxygen saturation (SaO2), [Hb] and arterial partial 194 
pressure of oxygen (mmHg) using the following formula: 195 
Equation 1: 196 
CaO2 (ml dl




+ 0.003×PaO2  
where [Hb] is the concentration of hemoglobin (g dL-1), 1.36 is the affinity of oxygen to 197 
hemoglobin, SaO2, is the percentage of hemoglobin saturated with oxygen, 0.003 is the fraction 198 
of free oxygen dissolved in the blood.  199 
 Renal reactivity on high-altitude day1 and high-altitude day7 was calculated using 200 
relative changes with respect to sea-level values as previously described (58). 201 
Equation 2: 202 











PaCO2 altitude - PaCO2 sea-level
 
Where HCO3
- is arterial bicarbonate (mmol L-1) and PaCO2 (mmHg) is partial pressure of arterial 203 
carbon dioxide  204 
 205 
Transthoracic echocardiography 206 
Echocardiography was performed using an ultrasound system (as above) and a phased-207 
array transducer (1.5 – 3.6 MHz M4S-RS, GE Healthcare, Piscataway, NJ, USA) by the same 208 
sonographer (V.L.M.). A three-lead electrocardiograph was attached to the participant and 209 
connected to the ultrasound system to allow cardiac cycle gating. Images were acquired at end 210 
expiration over five cardiac cycles and data was stored for later offline analysis (EchoPAC, GE 211 
Medical, Horton, Norway). Measurements were made in triplicate from different cardiac cycles 212 
and averaged for use in statistical analyses. With the participant lying supine, subcostal images 213 
were acquired for assessment of inferior vena cava diameter. With the participant in the left 214 
lateral decubitus position, images were acquired for assessment of cardiac function according to 215 
current guidelines (29). Left ventricular stroke volume using end-diastolic and end-systolic 216 
volume that, were derived using the Simpson’s biplane method from apical 4- and 2-chamber 217 
views. Cardiac output was calculated as stroke volume x heart rate. Total peripheral resistance 218 
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Renal artery diameter and blood flow were measured with a convex-array transducer (2.0 223 
– 5.5 MHz 4C-RS Probe, GE Healthcare, Piscataway, NJ, USA) on a commercially available 224 
ultrasound system (Vivid Q, GE Healthcare, Piscataway, NJ, USA) by a single trained 225 
sonographer (V.L.M). The probe was placed at the midpoint between the xiphoid process and the 226 
umbilicus where the aorta was identified in a transverse section and the origin of the renal 227 
arteries was obtained using B-mode. Images were collected for measurement of renal artery 228 
diameter and allowing subsequent calculation of cross-sectional area. Renal artery blood flow 229 
was calculated as the product of the cross-sectional area and the velocity-time integral (pulse-230 
wave Doppler). Absolute renal blood flow and normalized renal blood flow ([renal blood flow / 231 
cardiac output] *100) are reported. Renal vascular resistance was calculated as: mean arterial 232 
pressure (mmHg) / mean renal blood flow (ml/min). All measurements were made in triplicate 233 
from different cardiac cycles and averaged for use in statistical analyses.  234 
The product of renal blood flow (ml min-1) and CaO2 (ml dl
-1) was used to calculate 235 
convective RDO2: 236 
Equation 3: 237 
 RDO2 (ml O2 min
-1)=
mean renal blood flow ×CaO2
100
   238 
 239 
Urine collection and analysis 240 
Participants were asked to complete a 9-hour urinary collection to calculate glomerular 241 
filtration rate. Due to limitations associated with conducting field research, were unable to 242 
control for salt and fluid intake. Participants were asked to maintain normal drinking habitats 243 
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throughout the week of high-altitude and we specifically requested participants to drink a 244 
standardized 200 mL of water forty-five minutes before testing. Urine was refrigerated until 245 
analysis (4 °C). Urine pots were shaken vigorously before analysis to ensure a homogenous 246 
mixture. Volumes were measured using graduated cylinders. Urine analysis was performed using 247 
a DCA Vantage Analyzer (Siemens Healthineers Global; Germany) for creatinine and 248 
microalbumin. Creatinine clearance was used to calculate glomerular filtration rate using the 249 
standard formula: 250 
Equation 4:  251 




Where Ux is urine creatinine concentration (mol L-1), V is urine production rate (ml min-1) and 252 
Px is serum creatinine concentration (mol L-1). Glomerular filtration rate was then scaled to body 253 
surface area as determined through the Dubois and Dubois formula (8).  254 
 255 




(1-hematocrit)  (mean renal blood flow)
 
Where the ratio between glomerular filtration (ml/min/1.73m2  and renal plasma blood flow 258 
(renal blood flow [ml min-1]  1- hematocrit [%]) is expressed as a percent.  259 
 260 
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Muscle sympathetic nerve activity 261 
Muscle sympathetic nerve activity was measured in subset of individuals who 262 
participated in an associated study on high-altitude day7. As such basal muscle sympathetic 263 
nerve activity data and characteristics have been previously reported in nine participants (n=9; 7 264 
males; age 25 ± 3 years and BMI 23 ± 2) (42); however, these data are presented in the current 265 
manuscript to provide novel insight related to sympathetic-mediated mechanisms governing 266 
renal blood flow at high-altitude. Muscle sympathetic nerve activity was recorded from the 267 
peroneal nerve using microneurography as previously described (42). The raw sympathetic 268 
signal was amplified (preamplifier 1000× and variable-gain, isolated amplifier (10000×), band-269 
pass filtered (700–2000 Hz), rectified and integrated (Bio amp 16/30; ADInstruments, Australia). 270 
A suitable signal was confirmed by the presence of pulse-synchronous bursts of activity that 271 
increased in response to apnea, but not loud noise. Muscle sympathetic nerve activity raw and 272 
integrated signals were analysed using semi-automated peak detection algorithms (Labchart 8.0 273 
Pro; ADInstruments, Australia) and bursts were confirmed by a trained observer (L.L.S. and 274 
C.D.S.) based on physiological principles. To account for differences in microelectrode position, 275 
burst amplitude data were normalized by assigning a value of 100 to the largest burst observed. 276 
Mean muscle sympathetic nerve activity was expressed as integrated burst frequency (burst min-277 
1), incidence (burst 100 cardiac cycles-1) and total activity [mean burst amplitude × burst 278 
frequency (a.u.ꞏmin-1)]. 279 
 280 
Data and statistical analyses 281 
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Data was assessed for normality and variance using the Sharpiro-Wilk and the Bron-282 
Forsythe test. A linear mixed-effect model analysis was performed to test for significance 283 
between sea-level vs. high-altitude day1 vs. high-altitude day7. Tukey post-hoc analyses were 284 
used if main effects existed. Acute mountain sickness scores were assessed using paired 285 
nonparametric tests (Wilcoxon signed-rank test). Pearson product moment correlations were 286 
used to assess associations between: Δ RDO2 and glomerular filtration rate / renal reactivity; and 287 
renal blood flow and muscle sympathetic nerve activity. Statistical analyses were performed 288 
using Graph Pad, Prism 8.3.0. All reported data is presented as the mean ± SD with statistical 289 
significance set at p < 0.05  290 
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Results:   291 
Participants 292 
Participant demographics are presented in table 1. Twenty-four participants were 293 
recruited but only twenty-two full data sets across all three assessments were obtained because 294 
two participants (both male) did not complete measurements on high-altitude day7 due to 295 
unexpected departure back to Lima, Peru. The values for these two participants at sea-level and 296 
high-altitude day1 are included in the group analysis. Thirteen of the twenty-four participants 297 
had mild acute mountain sickness (Lake Louise scores between 3-5) (41) on high-altitude day1. 298 
All participants refrained from taking acetazolamide (i.e. diamox), and other medications for 299 
altitude (e.g. dexamethasone) or travel-related illness (anti-biotics).  No participants experienced 300 
acute mountain sickness on high-altitude day7. 301 
 302 
Blood gas changes with high-altitude 303 
High-altitude caused an initial decrease in both PaO2 and SaO2 that improved on high-304 
altitude day7 (table 2). PaCO2 decreased longitudinally with high-altitude, while HCO3
- was 305 
progressively decreased (table 2). Respiratory alkalosis developed on high-altitude day1 306 
(P<0.001); there was partial correction to pH via renal compensation on high-altitude day7 (table 307 
2). CaO2 decreased initially with high-altitude (P<0.001) but improved to pre-altitude values on 308 
high-altitude day7 (P=0.31) through increases in PaO2, SaO2 and hemoglobin concentration 309 
(figure 1B).  310 
 311 
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Cardiovascular, sympathetic and renal responses to high-altitude  312 
Diastolic pressure was elevated at high-altitude compared to sea-level (P=0.0092 table 3), 313 
but systolic and mean arterial pressure remained unchanged (P=0.30 P=0.098, respectfully table 314 
3) Cardiac output increased on high-altitude day1 compared to sea-level (P<0.001), but fell to 315 
sea-level values on high-altitude day7 (P=0.67; table 3). Total peripheral resistance decreased on 316 
high-altitude day1 (P=0.018), but not high-altitude day7 (P=0.62; table 3).  317 
Renal blood flow was decreased at high-altitude on high-altitude day1 by 17±15% but 318 
returned to sea-level values on high-altitude day7 (P=0.54; figure 1A). Accordingly, renal 319 
vascular resistance was increased on high-altitude day1 (P=0.016), but not high-altitude day7 320 
(P=0.76; table 4). RDO2 was decreased by -22±17% on high-altitude day1 (P<0.001), due to a 321 
simultaneous reduction in both renal blood flow and CaO2 but was normalized back to sea-level 322 
values on high-altitude day7 (-6±14%) (P=0.36; figure 1C). Total normalized sympathetic nerve 323 
activity was calculated in a subset of participants on high-altitude day7 and was negatively 324 
correlated with renal blood flow normalized to cardiac output (r=-0.69; P=0.039; See figure 325 
supplemental 1) (https://doi.org/10.6084/m9.figshare.12860744.v1). RAAS hormones: active 326 
renin, and plasma aldosterone concentration, both decreased at high-altitude (P=0.025 and 327 
P=0.018, respectively), while NT pro-BNP did not change (P=0.15; table 4).  328 
 329 
Association between renal oxygen delivery and renal reactivity 330 
Renal reactivity was increased between high-altitude day1 and high-altitude day7 331 
(P=0.0016). A positive correlation was found between Δ RDO2 and renal reactivity between sea-332 
level and high-altitude day7 (r=0.70; P<0.001; figure 2B) and between high-altitude day1 and 333 
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high-altitude day7 (r=0.49; P=0.022; figure 2C), but not between sea-level and high-altitude 334 
day1 (r=0.26; P=0.29 figure 2A). No relationships were found between Δ renal blood flow 335 
(r=0.10; P=0.67), Δ CaO2 (r=0.25; P=0.23), or Δ glomerular filtration rate (r=0.15; P=0.63), and 336 
renal reactivity on high-altitude day7.   337 
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Discussion: 338 
To our knowledge, this study is the first to assess RDO2 after rapid ascent to high-altitude 339 
in a large cohort of lowlander participants whom have refrained from taking high-altitude 340 
medications (e.g. acetazolamide). The main findings were: 1) there was a reduction in RDO2 on 341 
high-altitude day1; however, RDO2 was restored to sea-level values on high-altitude day7 342 
through an increase in both CaO2 and renal blood flow; and 2) the relative change in RDO2 at 343 
high-altitude compared to sea-level was associated with renal reactivity on high-altitude day7, 344 
indicating that acid-base regulation is linked to renal oxygenation after exposure to severe 345 
hypobaric hypoxia. Together, these data demonstrate that RDO2 is normalized after a week of 346 
high-altitude acclimatization and provides novel insight on the critical role of renal adaptation 347 
and acid-base balance under hypoxic conditions.  348 
 349 
Renal blood flow control at high-altitude 350 
Compared to ventilatory and hematological acclimatization responses (10, 13, 43, 55, 351 
57), less is known on the impact of renal blood flow on high-altitude acclimatization. While 352 
short exposure to hypoxia (e.g. 20 minutes) augments renal blood flow (5, 51), this is not 353 
apparent during chronic hypoxia (1, 37, 38, 43). Renal blood flow has been reported as 354 
unchanged (38), and decreased (37), after 48-hours at 4350 m, but longer duration studies 355 
(weeks) have shown a decrease in renal blood flow (1, 43). Together, these findings indicate that 356 
the renal blood flow response to hypoxia is highly dependent on exposure time. We saw an early 357 
high-altitude renal vasoconstriction with a decreased renal blood flow, which normalized to sea-358 
level values following a week of acclimatization. Numerous factors can influence renal blood 359 
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flow such as reactive oxygen species, RAAS, phosphodiesterase type 5 upregulation, renal 360 
sympathetic nerve activity, circulating catecholamines, natriuretic peptides and ET during 361 
hypoxia  (11, 16, 34, 36, 43, 52). In this investigation, NT pro-BNP was unchanged during 362 
acclimatization. However, analyzed venous blood samples for RAAS hormones both renin 363 
activity and plasma aldosterone concentrations were decreased occurring on high-altitude day7, 364 
but not high-altitude day1. Prolonged hypoxia may depress RAAS to increase excretory function. 365 
This depression would counter the effects of increased renal vascular resistance and may explain 366 
the observed +12% increase in renal blood flow seen between high-altitude day1 and high-367 
altitude day7 (37). The renal system may decrease renin secretion to preserve excretory function 368 
via decreased renal vascular resistance following a week of acclimatization (6, 38). 369 
Sympathetic nerve activity may also influence renal blood flow at high-altitude (10, 37, 370 
42). A previous study demonstrated that renal vascular vasodilation to dopamine at high-altitude 371 
(~48 hours at 4350 m) was attenuated, and plasma circulating norepinephrine concentrations 372 
were increased, indicating greater renal arteriole vasoconstriction potentially through increased 373 
adrenergic activity (37). Furthermore, a study conducted in dogs demonstrated an augmented 374 
renal blood flow response to hypoxia after kidney denervation (27), while another study 375 
conducted in conscious rabbits subjected to 0.14 and 0.10 fraction inspired oxygen content, had a 376 
14% and 38% increase in renal sympathetic nerve activity, respectively, and congruent decreases 377 
in renal blood flow that were abolished following renal denervation (34). In the current study, we 378 
observed a significant negative relationship between total normalized muscle sympathetic nerve 379 
activity and normalized renal blood flow on high-altitude day7 (See figure supplemental 1) 380 
(https://doi.org/10.6084/m9.figshare.12860744.v1). In other words, participants with greater total 381 
normalized muscle sympathetic nerve activity had lower normalized renal blood flows. 382 
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Collectively, this latter observation and previous findings (34, 37) would suggest the level of 383 
sympathetic nerve activity is an important determinant of renal blood flow during hypoxia. We 384 
acknowledge the requirement of sea-level and high-altitude day1 muscle sympathetic nerve 385 
activity data, as well as acute manipulation of sympathetic nerve activity, to draw further 386 
conclusions. 387 
 388 
RDO2 at high-altitude 389 
To date, no previous studies have calculated RDO2 at high-altitude in humans (48). The 390 
data from the current investigation demonstrated that only 12 hours of high-altitude exposure 391 
resulted in a concomitant decrease in renal blood flow and CaO2, resulting in a reduction in 392 
RDO2 by 22%. The acute reduction in RDO2 was offset by elevated CaO2 and renal blood flow 393 
after 7 days of high-altitude acclimatization (see figure 1). We report similar findings as a 394 
previous animal study (48). Since sodium tubular load accounts for 99.5% of renal metabolic 395 
activity (14, 25, 31), renal blood flow may decrease in order to limit renal oxygen consumption, 396 
effectively preserving oxygen for other organs (20, 33). This is supported by reciprocal changes 397 
in cardiac output and renal blood flow observed where renal blood flow decreased was by 17%, 398 
while cardiac output was augmented by 20%. The limited oxygen supply is being directed away 399 
from the metabolic demanding kidneys conserving systemic oxygen (20, 33). 400 
 401 
RDO2 and acid-base acclimatization 402 
There have been several previous studies that have characterized renal acid-base acclimatization 403 
at high-altitude. Renal alterations are initiated within two hours after the onset of hypocapnia, 404 
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and current data indicates incomplete pH compensation is present (metabolic alkalosis) at 405 
altitudes above 2800 m (17, 20, 28, 58). Renal reactivity, an index of acid-base compensation 406 
between HCO3
- and PaCO2 (Δ[HCO3
−]/Δ [PaCO2]), (58), has been shown to increase at altitudes 407 
up to 3800 m, and then decreases with further increases in altitude (58). In the current study, 408 
renal reactivity was greater on high-altitude day7 compared to high-altitude day1, indicating 409 
renal reactivity has a temporal component that is influenced by early acclimatization. Compared 410 
to Zouboules and colleagues (58) expedition, which was conducted at 4240 m after incremental 411 
ascent over seven days, we observed similar renal reactivity response to high-altitude. It is 412 
important to note, however, that the ascent profile used in this current study and Zouboules and 413 
colleagues (58) expedition were very different. For example, Zouboules and colleagues (58) 414 
trekked most days towards Everest basecamp where acclimatization was obviously influenced by 415 
the daily changes in altitude. In our study, we ascended via automobile to 4330 m where we 416 
resided for the duration of the study. Hence, the current study enabled the question of 417 
acclimatization to be addressed over time at the same altitude. Therefore, to address the question 418 
and to extend the data presented by Zouboules and colleagues (58), we assessed both renal 419 
reactivity and RDO2 at high-altitude, and found an association between these two physiological 420 
parameters on high-altitude day7 (see figure 2B and 2C). Interestingly, a relationship was not 421 
observed between renal reactivity and renal blood flow, CaO2 or glomerular filtration rate. One 422 
interpretation of these findings is that the reduction in renal blood flow or glomerular filtration 423 
rate seen at high-altitude (37, 39, 43) does not influence the kidneys capacity to filtrate and 424 
excrete HCO3
- in the urine as previously hypothesized (39, 58). Conversely, this may imply 425 
RDO2 influences the tubular handling of HCO3
−and H+ (18, 49). RDO2 at high-altitude may 426 
impact the activity of intracellular carbonic anhydrase (23), proton secretion via the Na+-H+ 427 
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exchanger (NHE3) (2) and/or activity of intercalated cells on the collecting ducts (15). However, 428 
considering the known linkage between sodium and HCO3
- reabsorption in the proximal tubule 429 
(18, 54), we must acknowledge that the independent influence of sodium on acid-base regulation. 430 
That is, renal reactivity and arterial HCO3
- may actually correlate with sodium excretion rather 431 
than changes in RDO2. We recommend that these findings be interpreted cautiously. Future 432 
endeavours should determine the influence of sodium (and other electrolyte) excretion on acid-433 
base regulation during acclimatization. 434 
 435 
Experimental limitations and considerations 436 
The current investigation was the first to assess RDO2 at high-altitude; however, there are 437 
some experimental considerations that warrant discussion. First, para-aminohippurate would 438 
provide a more specific measure of renal perfusion. However, renal ultrasound is strongly 439 
correlated to effective renal blood flow when flows are above 280 ml min-1 as seen this study 440 
(46). Second, muscle sympathetic nerve activity was recorded in a subset of individuals and used 441 
as a surrogate for renal sympathetic nerve activity. We acknowledge that sympathetic vasomotor 442 
outflow to skeletal muscle vasculature may not reflect renal sympathetic nerve activity and may 443 
exhibit differential reflex responses (42). While renal sympathetic nerve activity and muscle 444 
sympathetic nerve activity are strongly correlated in animals (26), these findings should be 445 
interpreted cautiously and used to inform future research. Third, salt and fluid intake was not 446 
controlled for during testing. We acknowledge that changes in fluid and salt may have 447 
contributed to the change in renal function and renal oxygen delivery (21). However, we feel this 448 
has limited influence on our findings. Previous findings have demonstrated that high-altitude 449 
changes renal blood flow and Sprague-Dawley rats during hypobaric hypoxia have a temporal 450 
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RDO2 response to our findings (48). Future endeavours should investigate this physiological 451 
phenomenon while controlling salt and fluid intake. Fourth, we did not calculate metabolic 452 
efficacy of sodium reabsorption across the proximal tubule or renal oxygen consumption. High-453 
altitude may change both of these to maintain normoxic filtration (48). However, this should be 454 
addressed in future studies specifically looking at renal metabolic function during hypobaric 455 
hypoxia. Lastly, no comparisons were made between sexes despite knowing there is a difference 456 
in renal blood flow and RAAS regulation between men and women (24). However, since this 457 
was a repeated measures assessment comparing within individuals and females were only a small 458 
subset this should not greatly impact our findings. Future endeavours should examine the impact 459 
of sex on RDO2 at high-altitude.  460 
 461 
Significance and perspective 462 
Our data characterizes renal acclimatization following 12-hours and one-week exposure 463 
to 4300 m. Renal oxygen delivery fell immediately with initial high-altitude exposure but was 464 
restored on high-altitude day7 by increases in both CaO2 and renal blood flow. In addition, 465 
relative changes to RDO2 from sea-level were positively correlated with renal reactivity on high-466 
altitude day7, indicating a potential link between RDO2 and acid-base compensation during high-467 
altitude acclimatization. Together, these data demonstrate that RDO2 is normalized following a 468 
week of acclimatization and may contribute to pH normalization.   469 
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Figure 1: RDO2 and determinants. RDO2 is acutely decreased during initial exposure to high-633 
altitude (4330 m), however increases to sea-level thereafter at high-altitude day7 from restored 634 
renal blood flow and CaO2. Participants were tested at sea-level (Kelowna, BC 344 m), the 635 
morning immediately following ascent having spent ~12-hours at high-altitude (high-altitude 636 
day1) (Cerro de Pasco, Peru 4330m) and again following seven days of acclimatization (high-637 
altitude day7) (Cerro de Pasco, Peru 4330m). 638 
 639 
 640 
Figure 2: Renal reactivity and Δ RDO2 at high-altitude day1, high-altitude day7 and 641 
between high-altitude day1 and high-altitude day7. While the change in renal reactivity 642 
between sea-level and high-altitude day1 was not associated with the concurrent change Δ RDO2 643 
(A), there was a strong correlation between the changes in renal reactivity and RDO2 when 644 
considering the differences between sea-level and high-altitude day7 (B).  There was also a 645 
correlation between changes renal reactivity and RDO2 during acclimatization (between high-646 
altitude days 1 and 7) (C). Renal reactivity is higher in participants with greater RDO2 647 
suggesting acid-base compensation is dictated by RDO2 at high-altitude. Participants were tested 648 
at sea-level (Kelowna, BC 344 m), the morning immediately following ascent having spent ~12-649 
hours at high-altitude (high-altitude day1) (Cerro de Pasco, Peru 4330m) and again following 650 
seven days of acclimatization (high-altitude day7) (Cerro de Pasco, Peru 4330m). 651 
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Table 1: Participant demographics and acute mountain sickness scores. 











Age 28 ± 6.4 - - - 
Weight (kg) 74 ± 8 73 ± 10 72 ± 10 0.57 
Height (cm) 176 ± 10 - - - 
BMI (kg m-1) 24.3 ± 2.4 23.6 ± 9.6 22.8 ± 3.5 0.19 
AMS scores - 3.0 ± 1.9 0.4 ± 0.9 # 0.046 
List of Abbreviations: BMI, body mass index; and AMS; acute mountain sickness. 
Participants were tested at sea-level (Kelowna, BC 344 m), the morning immediately following 
ascent having spent ~12-hours at high-altitude (high-altitude day1) (Cerro de Pasco, Peru 4330m) 
and again following seven days of acclimatization (high-altitude day7) (Cerro de Pasco, Peru 
4330m). 
P-value for a linear mixed-effect model analysis (effect of time) indicated for each variable. 
Symbols indicate significant post-hoc comparisons,  
# Represents a significant difference between Sea-level vs High-altitude day7 (p<0.05),  
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Table 2: Arterial blood data 











pH 7.43 ± 0.033 7.48 ± 0.034 * 7.45 ± 0.031 # <0.001 
Bicarbonate (mmol L-1) 25.8 ± 1.7 24.6 ± 1.9 19.9 ± 2.0 #† <0.001 
PaCO2 (mmHg) 38.4 ± 3.2 33.1 ± 3.3 * 28.2 ± 2.6 #† <0.001 
Renal reactivity (Δ[HCO3−]/Δ 
[PaCO2]) 
- 0.098±0.75 0.54±0.14† 0.0016 
PaO2 (mmHg) 100.6 ± 18.4 41.5 ± 7.3 * 50.7 ± 3.9 #† <0.001 
SaO2 (%) 97.6 ± 1.2 78.9 ± 8.4 * 87.6 ± 2.1 <0.001 
Hemoglobin (g dl-1) 14.2 ± 1.3 15.2 ± 1.1 15.6 ± 1.2 # <0.001 
Hematocrit (%) 42.3 ± 4.4 44.3 ± 2.7 46.5 ± 2.4 # <0.001 
CaO2 (ml dl-1) 15.2 ± 1.8 12.8 ± 1.7* 18.1 ± 1.4 † <0.001 
List of Abbreviations: PaO2, arterial partial pressure of oxygen and PaCO2, arterial partial pressure of 
carbon 
Participants were tested at sea-level (Kelowna, BC 344 m), the morning immediately following ascent 
having spent ~12-hours at high-altitude (high-altitude day1) (Cerro de Pasco, Peru 4330m) and again 
following seven days of acclimatization (high-altitude day7) (Cerro de Pasco, Peru 4330m). 
P-value for a linear mixed-effect model analysis indicated for each variable. Symbols indicate significant 
post-hoc comparisons,  
* Represents a significant difference between Sea-level vs High-altitude day1 (p<0.05), 
# Represents a significant difference between Sea-level vs High-altitude day7 (p<0.05),  
† Represents a significant difference between High-altitude day1 vs High-altitude day7 (p<0.05). 
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Table 3: Cardiovascular hemodynamics and muscle sympathetic nerve activity 












Heart rate (beats min-1) 56 ± 12 77 ± 13 * 66 ± 13 <0.001 
Cardiac output (L min-1) 4.0 ± 0.8 5.0 ± 1.1 * 4.1 ± 0.9 † <0.001 
Mean arterial pressure 
(mmHg) 
88 ± 6 89 ± 7 90 ± 8 0.098 
Systolic pressure (mmHg) 117 ± 9 118 ± 8 119 ± 10 0.30 
Diastolic pressure (mmHg) 70 ± 7 78 ± 7 * 76.± 7 0.001 
Total peripheral resistance 
(mmHg L-1 min-1) 
21.9 ± 3.9 18.9 ± 4.1 * 22.7 ± 4.6 † 0.001 
Muscle sympathetic nerve activity (n = 9) 
Burst frequency (bursts min-
1) 
- - 32 ± 15 - 
Burst incidence (bursts 
100HB-1) 
- - 42 ± 15 - 
Mean burst amplitude (a.u.) - - 39 ± 9 - 
Total activity (a.u. min-1)  - - 1284 ± 411 - 
List of Abbreviations: HB, heartbeat and a.u, arbitrary units 
Participants were tested at sea-level (Kelowna, BC 344 m), the morning immediately following 
ascent having spent ~12-hours at high-altitude (high-altitude day1) (Cerro de Pasco, Peru 4330m) 
and again following seven days of acclimatization (high-altitude day7) (Cerro de Pasco, Peru 
4330m). 
P-value for a linear mixed-effect model analysis indicated for each variable. Symbols indicate 
significant post-hoc comparisons,  
* Represents a significant difference between Sea-level vs High-altitude day1 (p<0.05), 
# Represents a significant difference between Sea-level vs High-altitude day7 (p<0.05),  
† Represents a significant difference between High-altitude day1 vs High-altitude day7 (p<0.05).
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Table 4: Renal function and volume regulatory hormones 












RDO2 (ml O2 min-1) 174.8 ± 71.7 137.9 ± 59.2* 164.9 ± 61.9† <0.001 
Renal blood flow (ml min-1) 924 ± 366 795 ± 351* 907 ± 312 0.019 
Normalized renal blood flow 
(%)  
23 ± 3 16 ± 3* 22 ± 4† <0.001 
Renal vascular resistance 
(mmHg ml-1 min-1) 
110 ± 50 129 ± 64 * 116 ± 47 0.046 
Glomerular filtration rate 
(ml/min/1.732) 
102 ± 20 91 ± 31 * 86 ± 17 # 0.005 
Filtration fraction (%) 21 ± 10  28 ± 9 * 24 ± 9 0.005 
Volume regulatory hormones 
Active renin (pg ml-1) 59.2 ± 23.1 49.4 ± 38.9 37.2 ± 24.1  0.025 
Plasma aldosterone 
concentration (pg ml-1) 
212.7 ± 104.9 175.1 ± 162.4 111.7 ± 92.5 # 0.018 
NT-pro-BNP (pg ml-1) 1753.1 ± 600.2 1909 ± 970.6 1460 ± 764.6 0.15 
Urinary volume (ml) (9 
hours) 
510 ± 198.5 680.1 ± 405.8 754.6 ± 255.8 # 0.022 
Urinary microalbumin (mg L-
1) 
5.9 ± 1.5 10.2 ± 3.5* 6.4 ± 2.0 0.012 
List of Abbreviations: NT pro-BNP, N-terminal pro-B-type natriuretic peptide and pg, picogram 
Participants were tested at sea-level (Kelowna, BC 344 m), the morning immediately following 
ascent having spent ~12-hours at high-altitude (high-altitude day1) (Cerro de Pasco, Peru 4330m) 
and again following seven days of acclimatization (high-altitude day7) (Cerro de Pasco, Peru 
4330m). 
P-value for a linear mixed-effect model analysis indicated for each variable. Symbols indicate 
significant post-hoc comparisons,  
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* Represents a significant difference between Sea-level vs High-altitude day1 (p<0.05), 
# Represents a significant difference between Sea-level vs High-altitude day7 (p<0.05),  
† Represents a significant difference between High-altitude day1 vs High-altitude day7 (p<0.05).
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Global REACH 2018: Renal oxygen delivery is 
maintained during early acclimatization to 4330 m  
Renal oxygen delivery at sea-level (344 m), after 12 
hours and 7 days at high-altitude (4330 m) METHODS 
 
CONCLUSION: Renal oxygen delivery is 
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